|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $49,155,167 | $33,576,156 | $34,341,327 | $27,388,918 | $44,689,661 | $44,302,643 | $44,737,220 |
| Streptomycins & their derivs.; salts thereof | $2,132,045 | $1,459,661 | $1,603,168 | $1,651,879 | $1,453,729 | $1,151,231 | $1,382,145 |
| Tetracyclines & their derivs.; salts thereof | $88,235,334 | $30,933,410 | $36,270,043 | $30,620,345 | $51,799,239 | $26,232,067 | $53,929,868 |
| Chloramphenicol & its derivs.; salts thereof | $157,839 | $158,988 | $174,264 | $192,270 | $234,581 | $794,060 | $390,401 |
| Erythromycin & its derivs.; salts thereof | $171,565 | $147,594 | $12,781,124 | $892,397 | $18,856,324 | $49,576,209 | $14,873,154 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $869,164,840 | $661,050,181 | $682,017,257 | $597,866,250 | $474,754,617 | $403,937,042 | $424,892,906 |
| Total | $1,009,016,790 | $727,325,990 | $767,187,183 | $658,612,059 | $591,788,151 | $525,993,252 | $540,205,694 |
|
|
